USCA 2007: What Do We Mean By "Evidence" in Evidence-Based HIV Prevention?
Download Quicktime version of this video (.mov, 320x240, 146.35MB)
(You must be logged in with a
free vimeo.com account to download the video. Sign up is quick and easy.)
Download the audio-only version of this session (.mp3, 2 hours, 25MB)
What Do We Mean By “Evidence” in Evidence-Based HIV Prevention?
A panel discussion at the United States Conference on AIDS (USCA) in Palm Springs, CA Thursday, November 8, 2007
Experts from research and program evaluation explored the range of types of evidence used to determine whether HIV prevention interventions and programs really "work." They discussed how evidence is gathered and assessed, from community-based programs to scientifically-designed randomized, controlled trials, and how these decisions affect choices about what programs to implement and scale-up.
Presenters
Dale Stratford, Ph.D.
Program Evaluation Branch
NCHHSTP/Division of HIV/AIDS Prevention
Centers for Disease Control and Prevention
Walt Senterfit, Ph.D., R.N., M.P.H.
National Board Chair
Community HIV/AIDS Mobilization Project,
CHAMP
William Bland, MPH, MBA
Director of Community Programs
San Francisco AIDS Foundation
Moderators
Judy Auerbach, Ph.D.
Deputy Executive Director for
Science and Public Policy
San Francisco AIDS Foundation
Monica S. Ruiz, Ph.D., MPH
Acting Director, Public Policy
amfAR, The Foundation for AIDS Research
Presented by the San Francisco AIDS Foundation and Caucus for Evidence-Based Prevention in partnership with amfAR, The Foundation for AIDS Research The AIDS Institute (TAI) The AIDS Vaccine Advocacy Coalition (AVAC) Community HIV/AIDS Mobilization Project (CHAMP) National Minority AIDS Council (NMAC) The Sexuality Information and Education Council of the United States (SIECUS)
Page last updated:
2/5/2008